Lower mean blood glucose during short‐term intensive insulin therapy is associated with long‐term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence‐based recommendations for standardization

Similar Items

• Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy
  od: Liu, Liehua, i dr.
  Izdano: (2012)
• Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes
  od: Xu, Lijuan, i dr.
  Izdano: (2020)
• Construction and Implications of Nomogram for Predicting Sustained Glycemic Remission After Short‐Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes
  od: Lijuan Xu, i dr.
  Izdano: (2025-08-01)
• Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study
  od: Ke, Weijian, i dr.
  Izdano: (2016)
• Attitudes Toward Diabetes Affect Maintenance of Drug-Free Remission in Patients With Newly Diagnosed Type 2 Diabetes After Short-Term Continuous Subcutaneous Insulin Infusion Treatment
  od: Chen, Ailing, i dr.
  Izdano: (2012)